Nephrology Section, Department of Internal Medicine, Ghent University Hospital, Belgium.
Nephrol Dial Transplant. 2010 May;25(5):1614-20. doi: 10.1093/ndt/gfp647. Epub 2009 Dec 4.
Absorption of large quantities of iodine, as induced by the use of topical antimicrobial povidone-iodine in burn-injured patients, may cause metabolic and electrolyte abnormalities as well as renal failure. To diminish iodine levels, haemodialysis was previously reported to be a suitable therapy. We therefore studied the kinetics of iodine in order to define the most optimal dialysis strategy.
Two patients with elevated iodine levels (93.6 and 81.2 mg/L) underwent continuous dialysis with blood flows Q(B) 150 and 120 mL/min. Blood was sampled from the inlet and outlet dialysis line at several time points during a 7-h and 39-h 10-min period, respectively. Samples were analysed for iodine with the inductively coupled plasma mass spectrometry (ICPMS) method. Kinetic analysis was performed using one and two compartmental models, deriving kinetic parameters: plasmatic volume V(1), extraplasmatic volume V(2) and intercompartmental clearance K(12). The calibrated kinetic model of Patient 2 was further used to simulate different dialysis strategies: 12-h per day with Q(B) 240, 6-h per day with Q(B) 480 and 240, and 12-h every 2 days with Q(B) 240. For each strategy, the mean average plasmatic and extraplasmatic concentration (TAC(p) and TAC(ep)) was calculated during 48 h.
Iodine seemed to follow one compartmental kinetics when serum sample collections were limited to the first 7 h of dialysis (Patient 1), but iodine appeared to be distributed in two volumes (V(1)=19.4 L, V(2)=38.0 L and K(12)=55 mL/min) when a longer observation period was taken into account (Patient 2). The simulations disclosed that 12-h dialysis per day with Q(B) 240 or continuous dialysis with Q(B) 120 resulted in the lowest TAC(p) (18.2 and 19.0 microg/L) and TAC(ep) (34.4 and 36.1 microg/L).
In patients with elevated iodine levels, especially when associated with renal failure, haemodialysis with a minimum 12-h duration with sufficient blood flow should be the first choice to remove iodine.
局部使用抗菌聚维酮碘会导致大量碘的吸收,从而引起代谢和电解质异常以及肾衰竭。为了降低碘水平,以前有报道称血液透析是一种合适的治疗方法。因此,我们研究了碘的动力学,以确定最理想的透析策略。
两名碘水平升高的患者(93.6 和 81.2mg/L)分别接受 Q(B)为 150 和 120mL/min 的连续透析。在 7 小时和 39 小时 10 分钟的过程中,分别在几个时间点从入口和出口透析线采集血液样本。使用电感耦合等离子体质谱法(ICPMS)方法分析碘。使用单室和双室模型进行动力学分析,得出动力学参数:血浆体积 V(1)、细胞外体积 V(2)和细胞间清除率 K(12)。进一步使用校准后的第 2 位患者的动力学模型模拟不同的透析策略:每天 12 小时,Q(B)为 240,每天 6 小时,Q(B)为 480 和 240,每 2 天 12 小时,Q(B)为 240。对于每种策略,在 48 小时内计算平均平均血浆和细胞外浓度(TAC(p)和 TAC(ep))。
当血清样本采集仅限于透析的前 7 小时时,碘似乎遵循单室动力学(患者 1),但当考虑更长的观察时间时,碘似乎分布在两个体积中(V(1)=19.4L,V(2)=38.0L 和 K(12)=55mL/min)(患者 2)。模拟结果表明,每天 12 小时透析,Q(B)为 240,或 Q(B)为 120 的连续透析可产生最低的 TAC(p)(18.2 和 19.0μg/L)和 TAC(ep)(34.4 和 36.1μg/L)。
对于碘水平升高的患者,特别是伴有肾衰竭的患者,应首选持续至少 12 小时、血流量充足的血液透析来清除碘。